From pathophysiology to therapy: dual and triple agonists as a new frontier in metabolic dysfunction-associated steatotic liver disease.

Research paper from Europe PMC. Evidence status: source reported.

Published

2026-10-13

Source reference

MED:42947668

DOI

10.3389/fphar.2026.1784959

Jurisdiction

Not assessed

Licence

Bibliographic metadata only; article rights retained

Argano C, Maggio D, Pollicino C, Cangialosi V, Biscaglia Manno S, Orlando V, Monti ML, Grutta A, Torres A, Corrao S. · Front Pharmacol · review-article; review; journal article · Found via: UK Biobank

Source: https://europepmc.org/article/MED/42947668. Captured 2026-10-31.

Limitations: Discovered through a Europe PMC keyword search for UK Biobank. A mention is not a verified link to an access authorisation, project, dataset or clinical outcome. Preprints may not be peer reviewed.